Question 1

What are the potential benefits of participating in this trial compared to standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the possible side effects of bicalutamide?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

Question 3

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the placebo mean for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bicalutamide (Casodex™) Versus Placebo in Patients With Early Prostate Cancer clinical trial (NCT00657904). Contact the study team or your healthcare provider for specific answers.

What this study is about